The main goal of adequate organ preservation is to avoid further cellular metabolism during the phase of ischemia. edema ending up in organ failure [14], [17], [18], [19], [20], [21], [22], [23]. Together with ICAM-1, VEGF is highly chemotactic BMS-777607 kinase inhibitor for inflammatory cells like monocytes [24], [25]. Clinically relevant effects of hypoxia induced… Continue reading The main goal of adequate organ preservation is to avoid further